OCUL - OCULAR THERAPEUTIX, INC

QQQ $ 441.04 $ 0.62 (0.14 %)

DIA $ 393.88 $ 3.74 (0.96 %)

SPY $ 519.76 $ 2.32 (0.45 %)

TLT $ 90.68 $ 0.64 (0.71 %)

GLD $ 216.23 $ 1.54 (0.72 %)

Previous Close

$ 5.75

Open

$ 5.73

Bid

$ 5.85 x 100

Ask

$ 5.87 x 100

Day's Range

$ 5.73 - $ 6.04

52 Week Range

$ 2.00 - $ 11.31

Volume

2,676,953

Average Volume

Market Cap

759.13M

Beta (5Y Monthly)

$ 1.45

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	03-11-2024	12-31-2023	10-K
3	11-07-2023	09-30-2023	10-Q
4	08-07-2023	06-30-2023	10-Q
5	05-08-2023	03-31-2023	10-Q
6	03-06-2023	12-31-2022	10-K
7	11-07-2022	09-30-2022	10-Q
8	08-08-2022	06-30-2022	10-Q
9	05-09-2022	03-31-2022	10-Q
10	02-28-2022	12-31-2021	10-K
11	11-08-2021	09-30-2021	10-Q
12	08-09-2021	06-30-2021	10-Q
13	05-05-2021	03-31-2021	10-Q
14	03-11-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-07-2020	06-30-2020	10-Q
17	05-08-2020	03-31-2020	10-Q
18	03-12-2020	12-31-2019	10-K
19	11-12-2019	09-30-2019	10-Q
20	08-07-2019	06-30-2019	10-Q
21	05-10-2019	03-31-2019	10-Q
22	03-07-2019	12-31-2018	10-K
23	11-07-2018	09-30-2018	10-Q
24	08-07-2018	06-30-2018	10-Q
25	05-08-2018	03-31-2018	10-Q
26	03-08-2018	12-31-2017	10-K
27	11-07-2017	09-30-2017	10-Q
28	08-08-2017	06-30-2017	10-Q
29	05-05-2017	03-31-2017	10-Q
30	03-10-2017	12-31-2016	10-K
31	11-09-2016	09-30-2016	10-Q
32	08-09-2016	06-30-2016	10-Q
33	05-10-2016	03-31-2016	10-Q
34	03-10-2016	12-31-2015	10-K
35	11-10-2015	09-30-2015	10-Q
36	08-10-2015	06-30-2015	10-Q
37	05-15-2015	03-31-2015	10-Q
38	03-20-2015	12-31-2014	10-K
39	11-12-2014	09-30-2014	10-Q
40	08-29-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Maintains Buy on Ocula...
05/08/2024 19:19:18

HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and lowers the price target fr...

JMP Securities Maintains Market Outperform...
05/08/2024 18:08:20

JMP Securities analyst Jonathan Wolleben maintains Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and lowers the ...

TD Cowen Maintains Hold on Ocular Therapeu...
05/08/2024 16:58:32

TD Cowen analyst Tara Bancroft maintains Ocular Therapeutix (NASDAQ:OCUL) with a Hold and lowers the price target from $11 t...

Ocular Therapeutix Q1 2024 Adj EPS $(0.28)...
05/07/2024 20:48:16

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of ...

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
05/06/2024 12:06:38

biontech-reports-downbeat-earnings-joins-medical-properties-trust-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

BioNTech Reports Downbeat Earnings, Joins ...
05/06/2024 11:32:06

Why Super Micro Computer Shares Are Tradin...
04/19/2024 17:25:08

HC Wainwright & Co. Reiterates Buy on Ocul...
04/19/2024 10:28:57

HC Wainwright & Co. analyst Yi Chen reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Buy and maintains $16 price target.

ocular-therapeutix-highlights-early-data-from-diabetes-related-eye-disorder

Ocular Therapeutix Highlights Early Data F...
04/18/2024 17:37:05

Ocular Therapeutix's Phase 1 HELIOS study unveils Axpaxli's efficacy in treating non-proliferative diabetic retinopathy...

why-las-vegas-sands-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why Las Vegas Sands Shares Are Trading Low...
04/18/2024 15:32:50

Ocular Therapeutix Reports Topline Phase 1...
04/18/2024 11:03:06

Ocular plans to present the study results at an upcoming meeting. AXPAXLI was generally well tolerated with no inflammation obs...

The Analyst Verdict: Ocular Therapeutix In...
04/16/2024 17:01:36

JMP Securities Reiterates Market Outperfor...
04/16/2024 15:13:37

JMP Securities analyst Jonathan Wolleben reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and maintains ...

Ocular Therapeutix Announced That Executiv...
04/15/2024 11:27:30

Reported Saturday, Ocular Therapeutix™ Ann...
04/08/2024 07:27:18

Phase 2 data highlight consistent and sustained reductions in Intraocular Pressure (IOP), statistically significant (p<0.0...

JMP Securities Reiterates Market Outperfor...
03/13/2024 15:34:33

JMP Securities analyst Jonathan Wolleben reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and maintains ...

Decoding 6 Analyst Evaluations For Ocular ...
03/13/2024 12:01:19

HC Wainwright & Co. Maintains Buy on Ocula...
03/13/2024 10:46:45

HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target fr...

Why Asana Shares Are Trading Lower By 11%?...
03/12/2024 18:07:31

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

these-analysts-boost-their-forecasts-on-ocular-therapeutix-after-q4-results

These Analysts Boost Their Forecasts On Oc...
03/12/2024 16:42:09

Ocular Therapeutix, Inc. (NASDAQ: OCUL) reported worse-than-expected fourth-quarter financial results on Monday.